Maximum quantity allowed is 999
请选择数量
CAS RN: 63547-13-7 | 產品號碼: A3194
產品規格
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 96.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Melting point | 151.0 to 154.0 °C |
| NMR | confirm to structure |
性質
| 熔點 | 153 °C |
| 水溶性 | Insoluble |
| Degree of solubility in water | < 1 g/l |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H302 : Harmful if swallowed. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
| RTECS # | AB8139500 |
運輸資料
| HS編碼* | 2930.90-900 |
Application
Adrafinil: A Synthetic Psychostimulant Agent Banned by the World Anti-Doping Agency
Adrafinil is a synthetic psychostimulant agent and a prodrug of modafinil [CAS: 68693-11-8] that is a wakefulness-promoting agent used for treatment of disorders such as narcolepsy and shift work sleep disorder. The precise mechanisms of action are still unknown. Modafinil has weak to negligible interactions with receptors for norepinephrine, serotonin, dopamine, etc. Modafinil was widely believed to serve as a selective α1-adrenergic receptor agonist. Recent work, however, in vitro, modafinil binds to the dopamine transporter and inhibits dopamine reuptake. This activity has been associated in vivo with increased extracellular dopamine levels in some brain regions of animals.
Adrafinil was sometimes used as a stimulatory agent in athletes, and were added to the prohibited list established by the World Anti-Doping Agency (WADA) in 2008. Therefore, the effective detection of adrafinil and its metabolites in human urine has been studied. (The product is for research purpose only.)
Adrafinil was sometimes used as a stimulatory agent in athletes, and were added to the prohibited list established by the World Anti-Doping Agency (WADA) in 2008. Therefore, the effective detection of adrafinil and its metabolites in human urine has been studied. (The product is for research purpose only.)
References
- Adrafinil: a novel vigilance promoting agent (a review)
- Adrafinil: effects on behavior and cognition in aged canines (a review)
- LC-ESI-MS determination and pharmacokinetics of adrafinil in rats
- Doping control analysis for adrafinil and its major metabolites in human urine
- Development of a validated LC method for enantiomeric separation and determination of adrafinil and its related substances on a Chiralcel OJ-H column connected to PDA and polarimetric detectors in series
- Fluorescent zinc and copper complexes for detection of adrafinil in paper-based microfluidic devices
考研文獻
TCIMail
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。